Michihide Tokuhira

1.8k total citations
80 papers, 1.4k citations indexed

About

Michihide Tokuhira is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Michihide Tokuhira has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 33 papers in Pathology and Forensic Medicine and 31 papers in Genetics. Recurrent topics in Michihide Tokuhira's work include Lymphoma Diagnosis and Treatment (31 papers), Chronic Lymphocytic Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Michihide Tokuhira is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), Chronic Lymphocytic Leukemia Research (28 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Michihide Tokuhira collaborates with scholars based in Japan, United States and Australia. Michihide Tokuhira's co-authors include Masahiro Kizaki, Tsutomu Takeuchi, Koichi Amano, Jun‐ichi Tamaru, Hayato Nagasawa, Alisa E. Koch, James M. Woods, Hideto Kameda, Michael V. Volin and Tetsuji Kamata and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Michihide Tokuhira

74 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michihide Tokuhira Japan 22 450 425 394 369 327 80 1.4k
Ingrid Simonitsch Austria 22 357 0.8× 365 0.9× 498 1.3× 149 0.4× 244 0.7× 54 1.4k
Metin Özdemirli United States 23 470 1.0× 112 0.3× 435 1.1× 175 0.5× 197 0.6× 82 1.7k
Carmen Bellas Spain 22 647 1.4× 120 0.3× 724 1.8× 388 1.1× 250 0.8× 59 1.9k
Alexander W. Hauswirth Austria 26 257 0.6× 488 1.1× 265 0.7× 376 1.0× 298 0.9× 64 2.0k
Judit Demeter Hungary 18 413 0.9× 426 1.0× 553 1.4× 146 0.4× 562 1.7× 117 1.6k
Christoph Walz Germany 25 375 0.8× 792 1.9× 186 0.5× 694 1.9× 679 2.1× 70 2.1k
P. Hutin France 13 697 1.5× 223 0.5× 99 0.3× 209 0.6× 151 0.5× 27 1.8k
Isabella Mosberger Austria 21 264 0.6× 146 0.3× 266 0.7× 130 0.4× 141 0.4× 25 1.2k
Pille Harrison United Kingdom 19 429 1.0× 413 1.0× 195 0.5× 1.0k 2.8× 359 1.1× 53 2.0k
Susumu Sugai Japan 25 267 0.6× 132 0.3× 349 0.9× 643 1.7× 164 0.5× 71 2.2k

Countries citing papers authored by Michihide Tokuhira

Since Specialization
Citations

This map shows the geographic impact of Michihide Tokuhira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michihide Tokuhira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michihide Tokuhira more than expected).

Fields of papers citing papers by Michihide Tokuhira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michihide Tokuhira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michihide Tokuhira. The network helps show where Michihide Tokuhira may publish in the future.

Co-authorship network of co-authors of Michihide Tokuhira

This figure shows the co-authorship network connecting the top 25 collaborators of Michihide Tokuhira. A scholar is included among the top collaborators of Michihide Tokuhira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michihide Tokuhira. Michihide Tokuhira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takaku, Tomoiku, Naoki Watanabe, Noriyoshi Iriyama, et al.. (2025). Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia. International Journal of Hematology.
2.
3.
4.
Tokuhira, Michihide, Yuta Kimura, Takayuki Tabayashi, et al.. (2023). Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. International Journal of Hematology. 118(2). 210–220. 1 indexed citations
5.
Tokuhira, Michihide, Jun‐ichi Tamaru, & Masahiro Kizaki. (2019). Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. Journal of Clinical and Experimental Hematopathology. 59(2). 72–92. 67 indexed citations
6.
Higashi, Morihiro, Ryutaro Kawano, Shuji Momose, et al.. (2019). Anaplastic large cell lymphoma with TP63 rearrangement: A dismal prognosis. Pathology International. 69(3). 155–159. 2 indexed citations
7.
Kimura, Yuta, M. Sagawa, Takayuki Tabayashi, et al.. (2018). [Human parvovirus B19-induced hemophagocytic lymphohistiocytosis and myocarditis in an adult patient with hereditary spherocytosis].. PubMed. 59(6). 682–687. 3 indexed citations
8.
Takaku, Tomoiku, Noriyoshi Iriyama, Michihide Tokuhira, et al.. (2018). Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database. Annals of Hematology. 97(11). 2081–2088. 21 indexed citations
9.
Nakaseko, Chiaki, Kaichi Nishiwaki, Hitoshi Ogasawara, et al.. (2018). Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan. International Journal of Hematology. 108(2). 176–183. 4 indexed citations
10.
Iriyama, Noriyoshi, Keiji Sugimoto, Eriko Sato, et al.. (2018). Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis. Medical Oncology. 35(11). 142–142. 3 indexed citations
11.
12.
Tokuhira, Michihide, Shuntaro Saito, Ayumi Okuyama, et al.. (2017). Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders. Blood. 130. 4024–4024. 1 indexed citations
13.
Iriyama, Noriyoshi, Michihide Tokuhira, Tomoiku Takaku, et al.. (2017). Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group. Leukemia Research. 54. 55–58. 13 indexed citations
14.
Tokuhira, Michihide, Shuntaro Saito, Ayumi Okuyama, et al.. (2017). Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leukemia & lymphoma. 59(5). 1143–1152. 50 indexed citations
15.
Tabayashi, Takayuki, M. Sagawa, Reiko Watanabe, et al.. (2013). Primary Cardiac Lymphoma in Non-Immunocompromised Patients: Three Case Reports and Review of the Literature. Annals of Oncology. 24. ix89–ix89.
16.
Uchida, Hideo, Koiti Inokuchi, Reiko Watanabe, Michihide Tokuhira, & Masahiro Kizaki. (2008). New therapeutic approaches to acute myeloid leukemia. Expert Opinion on Drug Discovery. 3(6). 689–706. 4 indexed citations
17.
Kameda, Hideto, Hayato Nagasawa, Hiroe Ogawa, et al.. (2005). Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.. PubMed. 32(9). 1719–26. 178 indexed citations
18.
Mori, Takehiko, Michihide Tokuhira, Shohei Mori, et al.. (2001). Primary natural killer cell lymphoma of the lacrimal sac. Annals of Hematology. 80(10). 607–610. 19 indexed citations
19.
Woods, James M., Kenneth J. Katschke, Michihide Tokuhira, et al.. (2000). Reduction of Inflammatory Cytokines and Prostaglandin E2 by IL-13 Gene Therapy in Rheumatoid Arthritis Synovium. The Journal of Immunology. 165(5). 2755–2763. 42 indexed citations
20.
Nakajima, Hideaki, Masahiro Kizaki, Yohko Kawai, et al.. (1996). CD7 Positive Acute Lymphoblastic Leukemia Successfully Treated with High Dose Cytosine Arabinoside and Mitoxantrone: A Case Report.. The Keio Journal of Medicine. 45(2). 114–117. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid Simonitsch Breakdown of academic impact, for papers by Metin Özdemirli Breakdown of academic impact, for papers by Carmen Bellas Breakdown of academic impact, for papers by Alexander W. Hauswirth Breakdown of academic impact, for papers by Judit Demeter Breakdown of academic impact, for papers by Christoph Walz Breakdown of academic impact, for papers by P. Hutin Breakdown of academic impact, for papers by Isabella Mosberger Breakdown of academic impact, for papers by Pille Harrison Breakdown of academic impact, for papers by Susumu Sugai
Rankless by CCL
2026